| Literature DB >> 29725797 |
.
Abstract
BACKGROUND: Gastrointestinal perforation is the most serious complication of typhoid fever, with a high disease burden in low-income countries. Reliable, prospective, contemporary surgical outcome data are scarce in these settings. This study aimed to investigate surgical outcomes following surgery for intestinal typhoid.Entities:
Mesh:
Year: 2018 PMID: 29725797 PMCID: PMC6132852 DOI: 10.1007/s00268-018-4624-8
Source DB: PubMed Journal: World J Surg ISSN: 0364-2313 Impact factor: 3.352
Fig. 1Study inclusion flowchart
Patient characteristics
| Child | Adult | |||
|---|---|---|---|---|
| Age (years) | Mean (SD) | 8.2 (3.8) | 31.5 (16.1) | < 0.001 |
| Gender | Male | 15 (44.1) | 37 (68.5) | 0.064 |
| Female | 15 (44.1) | 12 (22.2) | ||
| Missing | 4 (11.8) | 5 (9.3) | ||
| ASA | I (Normal/healthy) | 9 (26.5) | 19 (35.2) | 0.257 |
| II (Mild systemic disease) | 8 (23.5) | 18 (33.3) | ||
| III (Severe systemic disease) | 12 (35.3) | 11 (20.4) | ||
| IV (Severe systemic disease, constant threat to life) | 2 (5.9) | 5 (9.3) | ||
| V (Not expected to survive without the operation) | 1 (2.9) | 1 (1.9) | ||
| Unknown | 2 (5.9) | 0 (0.0) | ||
| Smoking status | Non-smoker | 34 (100.0) | 40 (74.1) | 0.005 |
| Current smoker | 0 (0.0) | 12 (22.2) | ||
| Missing | 0 (0.0) | 2 (3.7) | ||
| Diabetes | No | 34 (100.0) | 51 (94.4) | 0.162 |
| Yes | 0 (0.0) | 3 (5.6) | ||
| Antibiotic Prophylaxis | No | 3 (8.8) | 5 (9.3) | 0.945 |
| Yes | 31 (91.2) | 49 (90.7) | ||
| Time to operation | <6 h | 4 (11.8) | 22 (40.7) | 0.008 |
| >6 h | 29 (85.3) | 32 (59.3) | ||
| Missing | 1 (2.9) | 0 (0.0) | ||
| Bowel resection | No | 9 (26.5) | 13 (24.1) | 0.800 |
| Yes | 25 (73.5) | 41 (75.9) | ||
| WHO safer surgery checklist used? | No, not available | 12 (35.3) | 10 (18.5) | 0.205 |
| No, but available | 5 (14.7) | 9 (16.7) | ||
| Yes | 17 (50.0) | 35 (64.8) |
Numbers are n (%), unless otherwise indicated. All tests are Chi-square, where a Kruskal–Wallis test has been applied
Operative characteristics
| Child | Adult | ||
|---|---|---|---|
| G58 Small bowel: excision of small bowel | 5 (14.7) | 9 (16.7) | 0.272 |
| G67 Small bowel: other open operations on small bowel | 0 (0.0) | 2 (3.7) | |
| G74 Small bowel: formation of ileostomy | 2 (5.9) | 10 (18.5) | |
| G784 Small bowel: closure of perforation | 25 (73.5) | 30 (55.6) | |
| H06 Colon: extended excision of right hemicolon | 1 (2.9) | 0 (0.0) | |
| H07 Colon: excision of right hemicolon | 1 (2.9) | 0 (0.0) | |
| H15 Colon: formation of any colonic stoma | 0 (0.0) | 1 (1.9) | |
| J23 Gallbladder: other open operations on gall bladder | 0 (0.0) | 1 (1.9) | |
| T28 Abdomen: repair of anterior abdominal wall | 0 (0.0) | 1 (1.9) |
Numbers are n (%), unless otherwise indicated. All tests are Chi-square
30-day outcomes
| Child | Adult | |||
|---|---|---|---|---|
| Mortality (30 days) | Alive | 29 (85.3) | 51 (94.4) | 0.146 |
| Died | 5 (14.7) | 3 (5.6) | ||
| Reintervention (30 days) | No | 25 (73.5) | 44 (81.5) | 0.377 |
| Yes | 9 (26.5) | 10 (18.5) | ||
| Surgical site infection (30 days) | No | 11 (32.4) | 18 (33.3) | 0.924 |
| Yes | 23 (67.6) | 36 (66.7) | ||
| Organ space infection (30 days) | No | 30 (88.2) | 48 (88.9) | 0.684 |
| Yes | 4 (11.8) | 5 (9.3) | ||
| Missing | 0 (0.0) | 1 (1.9) |
Numbers are n (%), unless otherwise indicated. All tests are Chi-square
Model for 30-day mortality
| Alive | Died | OR (univariable) | OR (multilevel) | ||
|---|---|---|---|---|---|
| Age (years) | Mean (SD) | 22 (15.2) | 27.6 (32) | 1.02 (0.98–1.05, | 1.02 (0.98–1.06, |
| Gender | Male | 47 (65.3) | 5 (71.4) | – | – |
| Female | 25 (34.7) | 2 (28.6) | 0.75 (0.10–3.77, | – | |
| ASA | Under III | 55 (68.8) | 1 (12.5) | – | – |
| III and above | 25 (31.2) | 7 (87.5) | 15.40 (2.55–296.00, | 14.03 (1.55–127.16, | |
| Time to operation | <6 h | 25 (31.6) | 1 (12.5) | – | – |
| >6 h | 54 (68.4) | 7 (87.5) | 3.24 (0.54–62.28, | 2.46 (0.25–24.36, | |
| WHO safer surgery checklist used? | No, not available | 18 (22.5) | 4 (50.0) | – | – |
| No, but available | 13 (16.2) | 1 (12.5) | 0.35 (0.02–2.69, | 0.51 (0.04–6.69, | |
| Yes | 49 (61.3) | 3 (37.5) | 0.28 (0.05–1.36, | 0.36 (0.06–2.12, | |
| Antibiotic prophylaxis | No | 8 (10.0) | 0 (0.0) | – | – |
| Yes | 72 (90.0) | 8 (100.0) | 12,849,865.87 (0.00-NA, | – |
Univariable and multilevel models for 30-day mortality. Effect estimates are presented as odds ratios (ORs) alongside the corresponding 95% confidence interval
Model for 30-day surgical site infection
| No | Yes | OR (univariable) | OR (multilevel) | ||
|---|---|---|---|---|---|
| Age (years) | Mean (SD) | 22.9 (16) | 22.3 (17.8) | 1.00 (0.97–1.03, | 1.01 (0.97–1.04, |
| Gender | Male | 21 (80.8) | 31 (58.5) | – | – |
| Female | 5 (19.2) | 22 (41.5) | 2.98 (1.03–10.01, | 2.88 (0.86–9.69, | |
| ASA | Under III | 22 (75.9) | 34 (57.6) | – | – |
| III and above | 7 (24.1) | 25 (42.4) | 2.31 (0.88–6.61, | 2.27 (0.55–9.33, | |
| Time to operation | <6 h | 10 (35.7) | 16 (27.1) | – | – |
| >6 h | 18 (64.3) | 43 (72.9) | 1.49 (0.56–3.90, | 1.46 (0.39–5.48, | |
| WHO safer surgery checklist used? | No, not available | 9 (31.0) | 13 (22.0) | – | – |
| No, but available | 5 (17.2) | 9 (15.3) | 1.25 (0.32–5.22, | 0.77 (0.13–4.60, | |
| Yes | 15 (51.7) | 37 (62.7) | 1.71 (0.59–4.84, | 1.99 (0.31–12.96, | |
| Antibiotic prophylaxis | No | 3 (10.3) | 5 (8.5) | – | – |
| Yes | 26 (89.7) | 54 (91.5) | 1.25 (0.24–5.48, | 0.29 (0.02–3.90, |
Univariable and multilevel models for 30-day mortality. Effect estimates are presented as odds ratios (ORs) alongside the corresponding 95% confidence interval